Quantitative methods to monitor RNA biomarkers in myotonic dystrophy

Myotonic dystrophy type 1 (DM1) and type 2 (DM2) are human neuromuscular disorders associated with mutations of simple repetitive sequences in afected genes. The abnormal expansion of CTG repeats in the 3′-UTR of the DMPK gene elicits DM1, whereas elongated CCTG repeats in intron 1 of ZNF9/CNBP trig...

Full description

Bibliographic Details
Main Authors: Wojciechowska, Marzena, Sobczak, Krzysztof, Kozlowski, Piotr, Sedehizadeh, Saam, Wojtkowiak-Szlachcic, Agnieszka, Czubak, Karol, Markus, Robert, Lusakowska, Anna, Kaminska, Anna, Brook, J. David
Format: Article
Language:English
Published: Nature Publishing Group 2018
Online Access:https://eprints.nottingham.ac.uk/51160/
_version_ 1848798431575801856
author Wojciechowska, Marzena
Sobczak, Krzysztof
Kozlowski, Piotr
Sedehizadeh, Saam
Wojtkowiak-Szlachcic, Agnieszka
Czubak, Karol
Markus, Robert
Lusakowska, Anna
Kaminska, Anna
Brook, J. David
author_facet Wojciechowska, Marzena
Sobczak, Krzysztof
Kozlowski, Piotr
Sedehizadeh, Saam
Wojtkowiak-Szlachcic, Agnieszka
Czubak, Karol
Markus, Robert
Lusakowska, Anna
Kaminska, Anna
Brook, J. David
author_sort Wojciechowska, Marzena
building Nottingham Research Data Repository
collection Online Access
description Myotonic dystrophy type 1 (DM1) and type 2 (DM2) are human neuromuscular disorders associated with mutations of simple repetitive sequences in afected genes. The abnormal expansion of CTG repeats in the 3′-UTR of the DMPK gene elicits DM1, whereas elongated CCTG repeats in intron 1 of ZNF9/CNBP triggers DM2. Pathogenesis of both disorders is manifested by nuclear retention of expanded repeat containing RNAs and aberrant alternative splicing. The precise determination of absolute numbers of mutant RNA molecules is important for a better understanding of disease complexity and for accurate evaluation of the efficacy of therapeutic drugs. We present two quantitative methods, Multiplex Ligation-Dependent Probe Amplifcation and droplet digital PCR, for studying the mutant DMPK transcript (DMPKexpRNA) and the aberrant alternative splicing in DM1 and DM2 human tissues and cells. We demonstrate that in DM1, the DMPKexpRNA is detected in higher copy number than its normal counterpart. Moreover, the absolute number of the mutant transcript indicates its low abundance with only a few copies per cell in DM1 fibroblasts. Most importantly, in conjunction with fuorescence in-situ hybridization experiments, our results suggest that in DM1 fibroblasts, the vast majority of nuclear RNA foci consist of a few molecules of DMPKexpRNA.
first_indexed 2025-11-14T20:19:40Z
format Article
id nottingham-51160
institution University of Nottingham Malaysia Campus
institution_category Local University
language English
last_indexed 2025-11-14T20:19:40Z
publishDate 2018
publisher Nature Publishing Group
recordtype eprints
repository_type Digital Repository
spelling nottingham-511602018-04-17T14:45:57Z https://eprints.nottingham.ac.uk/51160/ Quantitative methods to monitor RNA biomarkers in myotonic dystrophy Wojciechowska, Marzena Sobczak, Krzysztof Kozlowski, Piotr Sedehizadeh, Saam Wojtkowiak-Szlachcic, Agnieszka Czubak, Karol Markus, Robert Lusakowska, Anna Kaminska, Anna Brook, J. David Myotonic dystrophy type 1 (DM1) and type 2 (DM2) are human neuromuscular disorders associated with mutations of simple repetitive sequences in afected genes. The abnormal expansion of CTG repeats in the 3′-UTR of the DMPK gene elicits DM1, whereas elongated CCTG repeats in intron 1 of ZNF9/CNBP triggers DM2. Pathogenesis of both disorders is manifested by nuclear retention of expanded repeat containing RNAs and aberrant alternative splicing. The precise determination of absolute numbers of mutant RNA molecules is important for a better understanding of disease complexity and for accurate evaluation of the efficacy of therapeutic drugs. We present two quantitative methods, Multiplex Ligation-Dependent Probe Amplifcation and droplet digital PCR, for studying the mutant DMPK transcript (DMPKexpRNA) and the aberrant alternative splicing in DM1 and DM2 human tissues and cells. We demonstrate that in DM1, the DMPKexpRNA is detected in higher copy number than its normal counterpart. Moreover, the absolute number of the mutant transcript indicates its low abundance with only a few copies per cell in DM1 fibroblasts. Most importantly, in conjunction with fuorescence in-situ hybridization experiments, our results suggest that in DM1 fibroblasts, the vast majority of nuclear RNA foci consist of a few molecules of DMPKexpRNA. Nature Publishing Group 2018-04-12 Article PeerReviewed application/pdf en cc_by https://eprints.nottingham.ac.uk/51160/1/s41598-018-24156-x.pdf Wojciechowska, Marzena, Sobczak, Krzysztof, Kozlowski, Piotr, Sedehizadeh, Saam, Wojtkowiak-Szlachcic, Agnieszka, Czubak, Karol, Markus, Robert, Lusakowska, Anna, Kaminska, Anna and Brook, J. David (2018) Quantitative methods to monitor RNA biomarkers in myotonic dystrophy. Scientific Reports, 8 . 5885/1-5885/13. ISSN 2045-2322 https://www.nature.com/articles/s41598-018-24156-x doi:10.1038/s41598-018-24156-x doi:10.1038/s41598-018-24156-x
spellingShingle Wojciechowska, Marzena
Sobczak, Krzysztof
Kozlowski, Piotr
Sedehizadeh, Saam
Wojtkowiak-Szlachcic, Agnieszka
Czubak, Karol
Markus, Robert
Lusakowska, Anna
Kaminska, Anna
Brook, J. David
Quantitative methods to monitor RNA biomarkers in myotonic dystrophy
title Quantitative methods to monitor RNA biomarkers in myotonic dystrophy
title_full Quantitative methods to monitor RNA biomarkers in myotonic dystrophy
title_fullStr Quantitative methods to monitor RNA biomarkers in myotonic dystrophy
title_full_unstemmed Quantitative methods to monitor RNA biomarkers in myotonic dystrophy
title_short Quantitative methods to monitor RNA biomarkers in myotonic dystrophy
title_sort quantitative methods to monitor rna biomarkers in myotonic dystrophy
url https://eprints.nottingham.ac.uk/51160/
https://eprints.nottingham.ac.uk/51160/
https://eprints.nottingham.ac.uk/51160/